FDA Approves Topamax for Migraine Prevention in Adolescents
Today, the U.S. Food and Drug Administration approved Topamax (topiramate) for prevention (prophylaxis) of migraine headaches in adolescents ages 12 to 17. This is the first FDA approval of a drug for migraine prevention in this age group. The medication is taken on a daily basis to reduce the frequency of migraine headaches.
Botox Little Help for Migraines
Botox -- perhaps best known for fighting wrinkles associated with aging -- also is approved as a treatment for chronic migraines, though studies evaluating its effectiveness as a headache reliever have been mixed.
New Migraine Guidelines Stress Prevention
Many patients suffering from chronic migraines may be eligible to take preventative medications, yet few take them. New guidelines for treating migraines stress using available therapies to prevent such attacks.